NCT05898087View on ClinicalTrials.gov

Subpectoral Bupivacaine for Pain Management in Adolescent Reduction Mammaplasty

PHASE4RecruitingINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

April 1, 2026

Study Completion Date

April 1, 2026

Conditions
MacromastiaPost-operative Pain
Interventions
DRUG

Marcaine 0.25 % Injectable Solution

Patients in this arm will receive an injection of 20cc of injectable 0.25% bupivacaine solution. It will be injected in a fan-like pattern beneath the pectoralis fascia

DRUG

Saline

Patients in this arm will receive an injection of 20cc of injectable saline. It will be injected in a fan-like pattern beneath the pectoralis fascia

Trial Locations (2)

06032

RECRUITING

Connecticut Children's, Farmington

06106

RECRUITING

Connecticut Children's, Hartford

All Listed Sponsors
lead

Connecticut Children's Medical Center

OTHER